LORUSSO, BRUNO
 Distribuzione geografica
Continente #
NA - Nord America 2.373
AS - Asia 2.103
EU - Europa 1.720
SA - Sud America 283
AF - Africa 124
OC - Oceania 6
Totale 6.609
Nazione #
US - Stati Uniti d'America 2.286
IT - Italia 711
SG - Singapore 613
CN - Cina 472
VN - Vietnam 405
BR - Brasile 207
BD - Bangladesh 192
IE - Irlanda 190
HK - Hong Kong 158
DE - Germania 151
SE - Svezia 132
FR - Francia 93
ZA - Sudafrica 74
GB - Regno Unito 69
NL - Olanda 68
AT - Austria 62
IN - India 62
FI - Finlandia 58
CA - Canada 49
RU - Federazione Russa 49
TR - Turchia 29
AR - Argentina 27
JP - Giappone 25
IQ - Iraq 23
PL - Polonia 23
MX - Messico 22
BE - Belgio 21
CZ - Repubblica Ceca 21
PH - Filippine 19
CI - Costa d'Avorio 18
KR - Corea 17
EC - Ecuador 16
PK - Pakistan 15
UA - Ucraina 15
ES - Italia 14
CO - Colombia 10
IR - Iran 10
TH - Thailandia 10
ID - Indonesia 8
LT - Lituania 8
MA - Marocco 8
TN - Tunisia 8
VE - Venezuela 8
SA - Arabia Saudita 7
AU - Australia 6
EG - Egitto 6
RO - Romania 6
AZ - Azerbaigian 5
GR - Grecia 5
JM - Giamaica 5
LU - Lussemburgo 5
PY - Paraguay 5
UY - Uruguay 5
UZ - Uzbekistan 5
IL - Israele 4
JO - Giordania 4
BG - Bulgaria 3
HN - Honduras 3
KE - Kenya 3
MY - Malesia 3
PE - Perù 3
TW - Taiwan 3
BB - Barbados 2
CH - Svizzera 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
MD - Moldavia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GP - Guadalupe 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 6.609
Città #
Ashburn 398
Singapore 367
Dallas 326
San Jose 209
Dublin 190
Parma 189
Chandler 159
Hong Kong 144
Ho Chi Minh City 123
Santa Clara 112
Boardman 107
Hanoi 89
New York 85
Beijing 79
Munich 77
Johannesburg 68
Los Angeles 66
Bologna 59
Ann Arbor 55
Vienna 54
Milan 53
Shanghai 47
Lauterbourg 44
Hefei 35
Buffalo 31
Dearborn 31
Helsinki 25
Frankfurt am Main 22
Moscow 22
Nanjing 22
Amsterdam 21
Chicago 21
Bremen 20
São Paulo 20
Turku 20
Brussels 19
Reggio Emilia 19
Verona 19
Abidjan 18
Haiphong 18
Toronto 18
Atlanta 17
Rome 17
Tokyo 17
Princeton 16
Warsaw 16
Izmir 15
London 15
Montreal 15
Brooklyn 14
Modena 14
Baghdad 12
Da Nang 12
Nanchang 12
Nuremberg 11
Rio Saliceto 11
Seoul 11
Columbus 10
Lahore 10
Seattle 10
West Jordan 10
Brno 9
Carpi 9
Chongqing 9
Denver 9
Olomouc 9
Redondo Beach 9
The Dalles 9
Trento 9
Brescia 8
Florence 8
Fremont 8
Guangzhou 8
Hebei 8
Marseille 8
Mumbai 8
Pune 8
Rio de Janeiro 8
Wilmington 8
Charlotte 7
Council Bluffs 7
Houston 7
Orem 7
Poplar 7
Curitiba 6
Jinan 6
Kyiv 6
Mexico City 6
Stockholm 6
Zhengzhou 6
Baku 5
Bari 5
Belo Horizonte 5
Bengaluru 5
Biên Hòa 5
Bolzano 5
Changsha 5
Chennai 5
Des Moines 5
Fidenza 5
Totale 4.039
Nome #
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 238
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 228
1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients 218
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 213
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 204
227P Sexual dimorphism in immune profile of early and advanced NSCLC 202
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 194
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 191
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 184
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 182
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 178
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 176
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 173
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 169
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 163
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 162
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 160
Assessment of Cardiac Patches Suitability for Tissue Engineering 159
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 158
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 157
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens 157
Isolation and characterization of human lung lymphatic endothelial cells 156
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 155
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 153
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 151
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 151
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 144
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 143
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 142
Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns acquired resistance to immunotherapy in patients with NSCLC 139
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 138
5P Blood immune-inflammatory dynamic unveils distinctive irAE features in ICI treated NSCLC 136
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 131
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 131
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia 130
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro 126
CD26 is differentially expressed throughout the life cycle of infantile hemangiomas and characterizes the proliferative phase 126
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 124
Deciphering the different patterns of acquired resistance in immunotherapy treated NSCLC patients through an integrated clinical and blood immuneinflammatory profiling 119
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 112
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 106
Deciphering multifaceted connections between NOTCH1 and SERCA2 proteins in the Darier's disease: a paradigmatic molecular network in the pathogenesis of a Mendelian genodermatosis 60
EHMT2/G9A drives the epigenetic regulation of glucose metabolism in T-cell Acute lymphoblastic leukemia 52
Totale 6.691
Categoria #
all - tutte 21.414
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.414


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/202291 8 5 2 6 1 4 15 7 2 5 4 32
2022/2023767 58 70 40 71 110 72 26 45 214 7 39 15
2023/2024510 24 22 21 26 50 72 83 20 31 48 29 84
2024/20251.247 63 64 92 112 113 82 105 74 116 102 109 215
2025/20263.641 288 227 547 361 385 211 298 160 509 269 231 155
Totale 6.691